Clinical Trial: Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access

Official Title: Clinical Protocol to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses

Brief Summary: The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.

Detailed Summary:
Sponsor: U.S. Army Medical Research and Materiel Command

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: U.S. Army Medical Research and Materiel Command

Dates:
Date Received: March 4, 2014
Date Started:
Date Completion:
Last Updated: November 10, 2016
Last Verified: August 2016